Russell Investments Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $215M | Buy |
555,321
+96,472
| +21% | +$35.8M | 0.19% | 82 |
|
|
2026
Q1 | $134M | Sell |
458,849
-50,851
| -10% | -$16.7M | 0.14% | 141 |
|
|
2025
Q4 | $179M | Sell |
509,700
-32,992
| -6% | -$11.1M | 0.19% | 90 |
|
|
2025
Q3 | $175M | Sell |
542,692
-25,511
| -4% | -$7.93M | 0.2% | 87 |
|
|
2025
Q2 | $221M | Sell |
568,203
-16,120
| -3% | -$6.48M | 0.28% | 60 |
|
|
2025
Q1 | $254M | Buy |
584,323
+49,129
| +9% | +$19.7M | 0.35% | 42 |
|
|
2024
Q4 | $197M | Buy |
535,194
+29,012
| +6% | +$12.1M | 0.27% | 59 |
|
|
2024
Q3 | $263M | Sell |
506,182
-79,024
| -14% | -$42.2M | 0.38% | 37 |
|
|
2024
Q2 | $316M | Sell |
585,206
-61,368
| -9% | -$32.4M | 0.51% | 19 |
|
|
2024
Q1 | $335M | Buy |
646,574
+35,881
| +6% | +$17.8M | 0.53% | 18 |
|
|
2023
Q4 | $288M | Buy |
610,693
+3,902
| +0.6% | +$1.8M | 0.51% | 20 |
|
|
2023
Q3 | $266M | Buy |
606,791
+70,884
| +13% | +$32.2M | 0.53% | 23 |
|
|
2023
Q2 | $238M | Sell |
535,907
-89,456
| -14% | -$41.3M | 0.46% | 26 |
|
|
2023
Q1 | $287M | Sell |
625,363
-16,733
| -3% | -$7.96M | 0.56% | 17 |
|
|
2022
Q4 | $329M | Buy |
642,096
+12,211
| +2% | +$6.2M | 0.68% | 11 |
|
|
2022
Q3 | $287M | Sell |
629,885
-58,429
| -8% | -$28M | 0.63% | 13 |
|
|
2022
Q2 | $333M | Buy |
688,314
+38,143
| +6% | +$18.9M | 0.68% | 13 |
|
|
2022
Q1 | $321M | Sell |
650,171
-4,139
| -0.6% | -$1.89M | 0.56% | 17 |
|
|
2021
Q4 | $304M | Buy |
654,310
+22,128
| +4% | +$9.31M | 0.49% | 19 |
|
|
2021
Q3 | $238M | Buy |
632,182
+43,774
| +7% | +$16.6M | 0.4% | 31 |
|
|
2021
Q2 | $225M | Buy |
588,408
+21,019
| +4% | +$8.03M | 0.38% | 31 |
|
|
2021
Q1 | $204M | Sell |
567,389
-1,259
| -0.2% | -$405K | 0.36% | 35 |
|
|
2020
Q4 | $181M | Sell |
568,648
-35,037
| -6% | -$10.8M | 0.36% | 40 |
|
|
2020
Q3 | $159M | Sell |
603,685
-21,491
| -3% | -$5.78M | 0.34% | 36 |
|
|
2020
Q2 | $163M | Sell |
625,176
-90,893
| -13% | -$24.2M | 0.36% | 37 |
|
|
2020
Q1 | $164M | Sell |
716,069
-47,245
| -6% | -$12.9M | 0.42% | 34 |
|
|
2019
Q4 | $232M | Sell |
763,314
-37,849
| -5% | -$10.4M | 0.43% | 28 |
|
|
2019
Q3 | $191M | Sell |
801,163
-95,395
| -11% | -$26.1M | 0.37% | 37 |
|
|
2019
Q2 | $253M | Sell |
896,558
-79,120
| -8% | -$21.6M | 0.47% | 26 |
|
|
2019
Q1 | $278M | Buy |
975,678
+104,940
| +12% | +$30.3M | 0.51% | 23 |
|
|
2018
Q4 | $227M | Buy |
870,738
+17,323
| +2% | +$4.76M | 0.51% | 24 |
|
|
2018
Q3 | $233M | Buy |
853,415
+21,522
| +3% | +$5.59M | 0.44% | 25 |
|
|
2018
Q2 | $198M | Sell |
831,893
-156,065
| -16% | -$36.1M | 0.41% | 34 |
|
|
2018
Q1 | $217M | Buy |
987,958
+2,443
| +0.2% | +$574K | 0.37% | 38 |
|
|
2017
Q4 | $224M | Buy |
985,515
+48,702
| +5% | +$10.4M | 0.38% | 36 |
|
|
2017
Q3 | $178M | Sell |
936,813
-13,700
| -1% | -$2.61M | 0.3% | 54 |
|
|
2017
Q2 | $179M | Sell |
950,513
-256,428
| -21% | -$46.1M | 0.32% | 54 |
|
|
2017
Q1 | $200M | Buy |
1,206,941
+14,076
| +1% | +$2.24M | 0.37% | 42 |
|
|
2016
Q4 | $173M | Buy |
+1,192,865
| New | +$160M | 0.34% | 45 |
|
Other funds holding ELV
AACR
Russell Investments Group's ELV Position: Q2 2026 in Review
Russell Investments Group increased its Elevance Health (ELV) stake by 21% in Q2 2026, buying an estimated $35.8M and bringing the position to 555,321 shares worth $215M. The position accounts for 0.19% of the portfolio, ranked #82.
Russell Investments Group first reported a position in ELV in Q4 2016 and has held it in 39 quarters since. The position peaked at $335M in Q1 2024. 917 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Russell Investments Group held 555,321 shares of Elevance Health worth $215M as of Q2 2026.
- Russell Investments Group bought 96,472 Elevance Health shares in Q2 2026, an estimated $35.8M.
- Elevance Health made up 0.19% of Russell Investments Group's portfolio in Q2 2026, its #82 holding.
- Russell Investments Group first reported a position in Elevance Health in Q4 2016 and has held it in 39 quarters since.
- Russell Investments Group's Elevance Health position peaked at $335M in Q1 2024.
- 917 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.